In This Article:
Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET)
PRESS RELEASE
2024 half-year results
-
Group results impacted by weaker economic conditions and continuing investment efforts in H1:
-
Revenue: €108.0m, -4.1%
-
Current Operating Income: €20.9m, -24.1%
-
-
Net Profit attributable to the Group: €17.2m, -21.8%
-
Though with a profit margin that continues to be very positive:
-
Ratio of Current Operating Income (COI) to Sales: 19.3% on a reported basis and 20.0% like-for-like
-
| H1 RESULTS (€M) | 2023 | 2024 | Change / Reported basis | External growth | Change / Like-for-like basis | ||
| Revenue | 112.6 | 108.0 | -4.6 | -4.1% | -3.7 | -8.3 | -7.4% |
| Current operating income (COI) | 27.5 | 20.9 | -6.6 | -24.1% | 0.0 | -6.7 | -24.3% |
| Net Profit | 22.9 | 18.1 | -4.8 | -21.0% | 0.0 | -4.8 | -21.1% |
| Net Profit attributable to the Group | 22.0 | 17.2 | -4.8 | -21.8% |
|
|
|
The financial statements for the six-month period ended 30 June 2024 were reviewed and adopted by EQUASENS' Board of Directors, chaired by Thierry Chapusot, on 27 September 2024. These interim consolidated financial statements were subject to a limited review by the Statutory Auditors.
_____
Results at 30 June 2024
| H1 Current Operating Income / Division | 2023 | 2024 | Change / Reported basis | External growth | Change / Like-for-like basis | ||
| Pharmagest | 18.4 | 14.1 | -4.3 | -23.5% | -0.1 | -4.4 | -24.0% |
| Axigate Link | 4.6 | 4.4 | -0.2 | -4.9% |
| -0.2 | -4.9% |
| e-Connect | 3.6 | 2.5 | -1.1 | -29.9% |
| -1.1 | -29.9% |
| Medical Solutions | 1.3 | 0.0 | -1.3 | -100.0% | 0.1 | -1.2 | -92.5% |
| Fintech | -0.4 | -0.1 | 0.3 | 69.3% |
| 0.3 | -69.3% |
| Current Operating Income | 27.5 | 20.9 | -6.6 | -24.1% | 0.0 | -6.7 | -24.3% |
-
PHARMAGEST division: a contraction in earnings reflecting lower sales and reinforced teams in Europe (COI/Sales: 17.2%)
The decline in the Division's operating income is mainly attributable to a reduction in sales in France in the configuration and hardware segment. In a persistently challenging economic environment, the Division continued to focus its commercial strategy on acquiring new customers and regularly rolling out new software and hardware solutions.
Despite this, recurring revenues were bolstered by the combined contribution of new SaaS offerings and contract indexation.
To accelerate the deployment of solutions in Europe, the R&D and sales teams continued to be strengthened.
-
AXIGATE LINK division: the profit margin remains high (COI/Sales: 28.6%)
Strategic investments to support the roll-out of SaaS solutions such as TitanLink for Nursing Homes in Europe, and the extension of homecare services, have temporarily weighed on the Division's results.
-
E-CONNECT division: current operating income declined in response to lower sales (COI/Sales: 45.4%)